Delta variant doubles risk of hospitalisation, new study finds

Outbreak of Delta Covid cases likely to put strain on health services in areas with low vaccination rates, experts say

The Delta variant doubles the risk of Covid hospitalisation compared with the previously dominant Alpha variant, a new study focused largely on unvaccinated or partially vaccinated people has found.

The analysis – based on data collected in England – suggests that outbreaks of the Delta variant are likely to put an additional strain on health services, particularly in places with low rates of vaccination.

The Delta variant, first identified in India, is already understood to be far more infectious than the previously dominant Alpha variant that was initially detected in Kent. This analysis underscores Delta’s ability to put people in hospital once infected, especially those who have not been vaccinated.

In the study, researchers analysed healthcare data from 43,338 Covid-19 cases in England between 29 March and 23 May 2021. Only 1.8% of the cases, regardless of variant, had received both doses of the vaccine, 24% had been vaccinated once and the majority (74%) were unvaccinated.

About one in 50 patients were admitted to hospital within 14 days of their first positive Covid test – 2.2% of Alpha cases vs 2.3% of Delta cases, the study found. However, after accounting for key factors such as age, ethnicity and vaccination status, the researchers found the risk of being admitted to hospital was more than doubled with the Delta variant compared with the Alpha variant (a 2.26-fold increase in risk), according to the paper published in the Lancet journal.

“This study confirms previous findings that people infected with Delta are significantly more likely to require hospitalisation than those with Alpha, although most cases included in the analysis were unvaccinated,” said Dr Gavin Dabrera, one of the study’s lead authors and a consultant epidemiologist for Public Health England.

“We already know that vaccination offers excellent protection against Delta and as this variant accounts for more than 98% of Covid-19 cases in the UK, it is vital that those who have not received two doses of vaccine do so as soon as possible.”

The researchers cautioned that the data could not be used to draw conclusions about how hospitalisation risk differs between vaccinated people who have been infected with either Delta or Alpha, given the small numbers of fully vaccinated people in the study.

In the study, samples of the virus taken from patients underwent whole genome sequencing to confirm which variant had caused the infection. Overall during the study period about 80% of the cases were attributed to Alpha, while the remainder were linked to Delta. However, in the final week of the study, Delta accounted for two-thirds of cases as the variant rose to dominance.

Previous research has generated similar findings. On the basis of PCR test results that determined the variant by testing for a specific gene that is more common in the Delta variant, early data from Scotland also pointed to a more than twofold higher risk of hospitalisation for those infected with the Delta variant compared with the Alpha variant.

Dr Anne Presanis, one of the study’s lead authors and senior statistician at the MRC Biostatistics Unit at the University of Cambridge, said the study’s findings highlighted the importance of vaccination.

It is already known that Delta is far more infectious, and this latest robust analysis has now confirmed that once infected, people are more likely to be hospitalised, noted Dr Peter English, a retired consultant in communicable disease control and the former chair of the British Medical Association’s public health medicine committee, who was not involved in the study.

Since most restrictions have been lifted – even with high vaccination rates – cases are on the rise and will probably climb higher as schools and universities reopen, he suggested, noting that the government’s roadmap to reopening was predicated on the Alpha not the Delta variant.

“The plans were not updated or changed to reflect the considerably higher risk posed by the Delta variant,” he noted. “And that strikes me as … wishful thinking on behalf of not very clever politicians, frankly.”

Contributor

Natalie Grover Science correspondent

The GuardianTramp

Related Content

Article image
The Covid Delta variant: how effective are the vaccines?
Analysis: what protection do they offer against infection, hospital admission and death?

Nicola Davis Science Correspondent

15, Jun, 2021 @2:38 PM

Article image
India variant could lead to serious third wave of Covid in UK
Analysis: If B.1.617.2 proves highly transmissible, hospitalisations could peak again, models show

Ian Sample Science editor

14, May, 2021 @3:58 PM

Article image
Offshoot of Covid Delta variant on the rise in England
UK Health Security Agency monitoring AY.4.2 as daily cases at highest level since late July

Nicola Davis

19, Oct, 2021 @11:09 AM

Article image
UK doctors urge public to get fully vaccinated as Delta variant spreads
Study finds Delta has nearly double risk of hospitalisation compared with previously dominant Alpha

Ian Sample Science editor

14, Jun, 2021 @2:00 PM

Article image
Experts study viability of giving flu and Covid jabs at same time
Findings on side-effects and vaccine efficacy expected by August or September as NHS prepares for potential flu surge

Natalie Grover Science correspondent

22, Jun, 2021 @2:09 PM

Article image
Covid mortality in England still higher for some ethnic minorities, study finds
People from Bangladeshi and Pakistani backgrounds faring worse than black people in second wave of pandemic

Natalie Grover

09, Feb, 2021 @6:00 AM

Article image
Covid vaccines may need updating to protect against new variant, study suggests
Neutralising ability of antibodies typically falls eight-fold with South African variant

Ian Sample and Linda Geddes

20, Jan, 2021 @4:15 PM

Article image
Delta variant causes more than 90% of new Covid cases in UK
Variant first discovered in India believed to spread more easily and be more resistant to vaccines

Nicola Davis Science correspondent

11, Jun, 2021 @12:22 PM

Article image
Flu and Covid jabs safe to be given at same time, study finds
Clinical trial on joint flu, Pfizer and AstraZeneca vaccinations reported only mild to moderate side-effects

Ian Sample Science editor

30, Sep, 2021 @9:00 PM

Article image
UK scientists back Covid boosters as study finds post-jab falls in antibodies
Exclusive: Waning antibody levels are possible warning sign of lower protection in months after vaccination

Ian Sample Science editor

22, Jul, 2021 @11:45 AM